Advisory Committee to the Director (ACD), Centers for Disease Control and Prevention (CDC), 58353 [2014-23054]

Download as PDF Federal Register / Vol. 79, No. 188 / Monday, September 29, 2014 / Notices DEPARTMENT OF HEALTH AND HUMAN SERVICES Notice of issuance of 10 Final Skin Notation Profile publications ACTION: Prevention and the Agency for Toxic Substances and Disease Registry. Centers for Disease Control and Prevention (NIOSH) of the Centers for Disease Control and Prevention (CDC), Department of Health and Human Services (HHS). Claudette Grant, Acting Director, Management Analysis and Services Office, Centers for Disease Control and Prevention. SUMMARY: Advisory Committee to the Director (ACD), Centers for Disease Control and Prevention (CDC) Substance(s) In accordance with section 10(a)(2) of the Federal Advisory Committee Act (Pub. L. 92–463), the Centers for Disease Control and Prevention (CDC) announces the following meeting of the aforementioned committee: The National Institute for Occupational Safety and Health (NIOSH) of the Centers for Disease Control and Prevention (CDC) announces the availability of the following 10 Skin Notation Profiles: Allyl glycidyl ether: http:// www.cdc.gov/niosh/docs/2014-143/ pdfs/2014-143.pdf. 2-Diethylaminoethanol: http:// www.cdc.gov/niosh/docs/2014-140/ pdfs/2014-140.pdf. 2-Ethoxyethyl acetate: http:// www.cdc.gov/niosh/docs/2014-141/ pdfs/2014-141.pdf. Ethyl acrylate: http://www.cdc.gov/ niosh/docs/2014-144/pdfs/2014144.pdf. Isophorone diisocyanate: http:// www.cdc.gov/niosh/docs/2014-144/ pdfs/2014-144.pdf. 2-Mercaptobenzothiazole (MBT); Sodium 2–MBT; Zinc 2–MBT: http:// www.cdc.gov/niosh/docs/2014-142/ pdfs/2014-142.pdf. Methyl isocyanate: http:// www.cdc.gov/niosh/docs/2014-145/ pdfs/2014-145.pdf. Nitrobenzene: http://www.cdc.gov/ niosh/docs/2014-146/pdfs/2014146.pdf. Phenylhydrazine: http:// www.cdc.gov/niosh/docs/2014-147/ pdfs/2014-147.pdf. Propargyl alcohol: http:// www.cdc.gov/niosh/docs/2014-149/ pdfs/2014-149.pdf. These documents are available at the following Web site: http://www.cdc.gov/niosh/topics/skin/ skin-notation_profiles.html ADDRESSES: FOR FURTHER INFORMATION CONTACT: tkelley on DSK3SPTVN1PROD with NOTICES Naomi Hudson, Dr.P.H.: NIOSH, 1090 Tusculum Ave., MS–C32, Cincinnati, OH 45226, Telephone: (513) 533–8540, email: iuz8@cdc.gov. Dated: September 22, 2014. John Howard, Director, National Institute for Occupational Safety and Health, Centers for Disease Control and Prevention. [FR Doc. 2014–23086 Filed 9–26–14; 8:45 am] BILLING CODE 4163–19–P VerDate Sep<11>2014 16:44 Sep 26, 2014 Jkt 232001 58353 Time and Date: 8:30 a.m.–3:00 p.m. (EDT), October 23, 2014. Place: CDC, Building 21, Rooms 1204 A/B, 1600 Clifton Road NE., Atlanta, Georgia 30333 Status: Open to the public, limited only by the space and phone lines available. The meeting room accommodates approximately 50 people. (Advance registration for inperson participation is required by October 16, 2014.) The public is welcome to participate during the public comment period, which is tentatively scheduled from 2:40 p.m. to 2:45 p.m. This meeting will also be available by: Teleconference: Please dial (877) 930–8819 and enter code 1579739. Web links: Windows Media: (Closed captioning will be available) http:// wm.onlinevideoservice.com/CDC1 Flash: http://www.onlinevideoservice.com/ clients/CDC/?mount=CDC3. If you are unable to connect using the link, copy and paste the link into your Web browser. For technical support please call: (404) 639–3737. Purpose: The committee will provide advice to the CDC Director on strategic and other broad issues facing CDC. Matters for Discussion: The Advisory Committee to the Director will receive updates from the State, Tribal, Local and Territorial Subcommittee; the Health Disparities Subcommittee, the Global Workgroup, the Internal and External Laboratory Safety Workgroups, and the Public Health—Health Care Collaboration Workgroup, the Ebola response, as well as an update from the CDC Director. Agenda items are subject to change as priorities dictate. For More Information Contact: Carmen Villar, MSW, Designated Federal Officer, ACD, CDC, 1600 Clifton Road, NE., M/S D– 14, Atlanta, Georgia 30333. Telephone (404) 639–7158, Email: GHickman@cdc.gov. The deadline to register for in-person attendance at this meeting is October 16, 2014. To register, please send an email to GHickman@ cdc.gov. The Director, Management Analysis and Services Office, has been delegated the authority to sign Federal Register notices pertaining to announcements of meetings and other committee management activities, for both the Centers for Disease Control and PO 00000 Frm 00041 Fmt 4703 Sfmt 4703 [FR Doc. 2014–23054 Filed 9–26–14; 8:45 am] BILLING CODE 4163–18–P DEPARTMENT OF HEALTH AND HUMAN SERVICES Centers for Disease Control and Prevention Request for Nominations of Candidates To Serve on the Board of Scientific Counselors (BSC), Office of Infectious Diseases (OID) The Centers for Disease Control and Prevention (CDC) is soliciting nominations for possible membership on the BSC, OID. This board consists of 17 experts in fields related to infectious diseases who are selected by the Secretary of the U.S. Department of Health and Human Services (HHS). The board advises the HHS Secretary; the CDC Director; the OID Director; and the Directors of the National Center for Immunization and Respiratory Diseases (NCIRD), the National Center for Emerging and Zoonotic Infectious Diseases (NCEZID), and the National Center for HIV/AIDS, Viral Hepatitis, STD, and TB Prevention (NCHHSTP) concerning strategies, goals, and priorities for the programs and research within the national centers; and monitors the overall strategic direction and focus of OID and the national centers. Nominations are being sought for individuals who have expertise and qualifications necessary to contribute to the accomplishment of the board’s mission. Nominees will be selected by the HHS Secretary or designee from authorities knowledgeable in the fields of infectious diseases and related disciplines, including epidemiology, microbiology, bacteriology, virology, pathogen genomics, bioinformatics, clinical medicine, and veterinary medicine, as well as from the general public. Members may be invited to serve for terms of up to four years. The U.S. Department of Health and Human Services policy stipulates that committee membership shall be balanced in terms of professional training and background, points of view represented, and the committee’s function. In addition to a broad range of expertise, consideration is given to a broad representation of geographic areas within the U.S., with diverse E:\FR\FM\29SEN1.SGM 29SEN1

Agencies

[Federal Register Volume 79, Number 188 (Monday, September 29, 2014)]
[Notices]
[Page 58353]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: 2014-23054]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Centers for Disease Control and Prevention


Advisory Committee to the Director (ACD), Centers for Disease 
Control and Prevention (CDC)

    In accordance with section 10(a)(2) of the Federal Advisory 
Committee Act (Pub. L. 92-463), the Centers for Disease Control and 
Prevention (CDC) announces the following meeting of the aforementioned 
committee:

    Time and Date: 8:30 a.m.-3:00 p.m. (EDT), October 23, 2014.
    Place: CDC, Building 21, Rooms 1204 A/B, 1600 Clifton Road NE., 
Atlanta, Georgia 30333
    Status: Open to the public, limited only by the space and phone 
lines available. The meeting room accommodates approximately 50 
people. (Advance registration for in-person participation is 
required by October 16, 2014.) The public is welcome to participate 
during the public comment period, which is tentatively scheduled 
from 2:40 p.m. to 2:45 p.m. This meeting will also be available by:
    Teleconference: Please dial (877) 930-8819 and enter code 
1579739.
    Web links: Windows Media: (Closed captioning will be available) 
http://wm.onlinevideoservice.com/CDC1
    Flash: http://www.onlinevideoservice.com/clients/CDC/?mount=CDC3.
    If you are unable to connect using the link, copy and paste the 
link into your Web browser. For technical support please call: (404) 
639-3737.
    Purpose: The committee will provide advice to the CDC Director 
on strategic and other broad issues facing CDC.
    Matters for Discussion: The Advisory Committee to the Director 
will receive updates from the State, Tribal, Local and Territorial 
Subcommittee; the Health Disparities Subcommittee, the Global 
Workgroup, the Internal and External Laboratory Safety Workgroups, 
and the Public Health--Health Care Collaboration Workgroup, the 
Ebola response, as well as an update from the CDC Director. Agenda 
items are subject to change as priorities dictate.
    For More Information Contact: Carmen Villar, MSW, Designated 
Federal Officer, ACD, CDC, 1600 Clifton Road, NE., M/S D-14, 
Atlanta, Georgia 30333. Telephone (404) 639-7158, Email: 
GHickman@cdc.gov. The deadline to register for in-person attendance 
at this meeting is October 16, 2014. To register, please send an 
email to GHickman@cdc.gov.
    The Director, Management Analysis and Services Office, has been 
delegated the authority to sign Federal Register notices pertaining 
to announcements of meetings and other committee management 
activities, for both the Centers for Disease Control and Prevention 
and the Agency for Toxic Substances and Disease Registry.

Claudette Grant,
Acting Director, Management Analysis and Services Office, Centers for 
Disease Control and Prevention.
[FR Doc. 2014-23054 Filed 9-26-14; 8:45 am]
BILLING CODE 4163-18-P